Articular Cartilage Clinical Trials

1 recruiting

Frequently Asked Questions

Common questions about Articular Cartilage clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 17 of 7 trials

Recruiting
Phase 2

Platelet Rich Plasma Injections In Young And Old Human Subjects

OsteoarthritisMusculoskeletal DisordersArticular Cartilage
University of California, San Francisco60 enrolled1 locationNCT06451120
Recruiting
Not Applicable

Introduction of ACI for Cartilage Repair

Chondral DefectArticular Cartilage DefectOsteochondritis
Centre Hospitalier Universitaire Vaudois218 enrolled1 locationNCT04296487
Recruiting
Phase 3

A Study of MACI in Patients Aged 17 to 65 Years With Symptomatic Chondral or Osteochondral Defects of the Ankle

Chondral DefectArticular Cartilage Defect
Vericel Corporation309 enrolled4 locationsNCT06915233
Recruiting
Phase 1

Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases

Malignant Neoplasm of Bone and Articular CartilageMalignant Neoplasms of Female Genital OrgansMalignant Neoplasms of Independent (Primary) Multiple Sites+7 more
M.D. Anderson Cancer Center44 enrolled1 locationNCT03093909
Recruiting
Phase 3

A Study of MACI in Patients Aged 10 to 17 Years With Symptomatic Chondral or Osteochondral Defects of the Knee

Chondral DefectOsteochondritis Dissecans (OCD)Articular Cartilage Defect+1 more
Vericel Corporation45 enrolled12 locationsNCT03588975
Recruiting
Not Applicable

Microfracture Versus Adipose Derived Stem Cells for the Treatment of Articular Cartilage Defects

Degenerative Lesion of Articular Cartilage of Knee
University of Colorado, Denver17 enrolled3 locationsNCT02090140
Recruiting
Not Applicable

Autologous Costal Osteochondral Transplantation for Talar Osteochondral Lesions

Articular Cartilage Defect
The Third Affiliated Hospital of Southern Medical University50 enrolled1 locationNCT05942430